Literature DB >> 16954601

Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.

Ester Schallmach1, Debora Steiner, Zvi Vogel.   

Abstract

Chronic exposure to opiate agonists (followed by agonist withdrawal) leads to a large increase in the activity of adenylyl cyclase (AC) isozymes I, V, VI, and VIII, a phenomenon defined as AC superactivation (or supersensitization). On the other hand, AC isozymes belonging to the AC-II family (AC-II, AC-IV, and AC-VII) show decreased activity, referred to as superinhibition. Using COS-7 cells transiently transfected with mu-opioid receptor and AC-II, we show here that inhibition of PKC and tyrosine kinase activities synergistically reduced the level of AC-II superinhibition. Moreover, inhibitor of Raf-1 kinase also led to a decrease in AC-II superinhibition. These data suggest that Raf-1, activated by PKC and tyrosine kinase, has a role in the regulation of AC-II superinhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954601     DOI: 10.1385/JMN:29:2:115

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  Binding of Gbetagamma subunits to cRaf1 downregulates G-protein-coupled receptor signalling.

Authors:  J R Slupsky; U Quitterer; C K Weber; P Gierschik; M J Lohse; U R Rapp
Journal:  Curr Biol       Date:  1999-09-09       Impact factor: 10.834

2.  Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation.

Authors:  M L Bayewitch; I Nevo; T Avidor-Reiss; R Levy; W F Simonds; Z Vogel
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

Review 3.  G protein regulation of adenylate cyclase.

Authors:  W F Simonds
Journal:  Trends Pharmacol Sci       Date:  1999-02       Impact factor: 14.819

Review 4.  Molecular mechanisms for heterologous sensitization of adenylate cyclase.

Authors:  Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

5.  Protein kinase C alters the responsiveness of adenylyl cyclases to G protein alpha and betagamma subunits.

Authors:  G Zimmermann; R Taussig
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

6.  Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits.

Authors:  M L Bayewitch; T Avidor-Reiss; R Levy; T Pfeuffer; I Nevo; W F Simonds; Z Vogel
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

7.  Gi-mediated stimulation of type II adenylyl cyclase is augmented by Gq-coupled receptor activation and phorbol ester treatment.

Authors:  R C Tsu; Y H Wong
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Differential activation of adenylyl cyclase by protein kinase C isoenzymes.

Authors:  J Kawabe; G Iwami; T Ebina; S Ohno; T Katada; Y Ueda; C J Homcy; Y Ishikawa
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

10.  Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation.

Authors:  Eva V Varga; Marc Rubenzik; Vanessa Grife; Masano Sugiyama; Dagmar Stropova; William R Roeske; Henry I Yamamura
Journal:  Eur J Pharmacol       Date:  2002-09-06       Impact factor: 4.432

View more
  5 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Authors:  Liz Kinast; Juliane von der Ohe; Heike Burhenne; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

3.  A novel noncanonical signaling pathway for the μ-opioid receptor.

Authors:  Lei Zhang; Horace H Loh; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2013-09-23       Impact factor: 4.436

4.  Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal.

Authors:  Lei Zhang; Hui Zhao; Yu Qiu; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2008-11-24       Impact factor: 5.157

5.  Morphine as a Potential Oxidative Stress-Causing Agent.

Authors:  Jitka Skrabalova; Zdenka Drastichova; Jiri Novotny
Journal:  Mini Rev Org Chem       Date:  2013-11       Impact factor: 2.495

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.